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Abstract
Background: Some popular weight loss diets restricting carbohydrates (CHO) claim to be more effective, and have
additional health benefits in preventing cardiovascular disease compared to balanced weight loss diets.
Methods and Findings: We compared the effects of low CHO and isoenergetic balanced weight loss diets in overweight
and obese adults assessed in randomised controlled trials (minimum follow-up of 12 weeks), and summarised the effects on
weight, as well as cardiovascular and diabetes risk. Dietary criteria were derived from existing macronutrient
recommendations. We searched Medline, EMBASE and CENTRAL (19 March 2014). Analysis was stratified by outcomes at
3–6 months and 1–2 years, and participants with diabetes were analysed separately. We evaluated dietary adherence and
used GRADE to assess the quality of evidence. We calculated mean differences (MD) and performed random-effects meta-
analysis. Nineteen trials were included (n = 3209); 3 had adequate allocation concealment. In non-diabetic participants, our
analysis showed little or no difference in mean weight loss in the two groups at 3–6 months (MD 0.74 kg, 95%CI 21.49 to
0.01 kg; I2 = 53%; n = 1745, 14 trials; moderate quality evidence) and 1–2 years (MD 0.48 kg, 95%CI 21.44 kg to 0.49 kg;
I2 = 12%; n = 1025; 7 trials, moderate quality evidence). Furthermore, little or no difference was detected at 3–6 months and
1–2 years for blood pressure, LDL, HDL and total cholesterol, triglycerides and fasting blood glucose (.914 participants). In
diabetic participants, findings showed a similar pattern.
Conclusions: Trials show weight loss in the short-term irrespective of whether the diet is low CHO or balanced. There is
probably little or no difference in weight loss and changes in cardiovascular risk factors up to two years of follow-up when
overweight and obese adults, with or without type 2 diabetes, are randomised to low CHO diets and isoenergetic balanced
weight loss diets.
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Background
Overweight, obesity and the related burdens of cardiovascular
disease (CVD), type 2 diabetes, other non-communicable diseases
(NCD) and premature mortality are escalating globally [1–3].
Nearly 80% of annual NCD deaths occur in low and middle
income populations [4] and the NCD burden is projected to rise
disproportionately in these populations over the next ten years [5].
Some weight loss diets widely promoted through the media,
such as the Atkins diet [6,7], recommend a regimen greatly
restricting carbohydrates (CHO), with increased protein and
unrestricted total and saturated fat intake. Advocates claim these
diets are more effective for losing weight compared to balanced
weight loss diets and also improve cardiovascular health, and
prevent or cure diabetes [8]. To achieve the very low CHO intake,
these diets prescribe restriction of most vegetables and fruit,
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wholegrains, legumes and other carbohydrate-containing foods. It
is plausible that these low CHO diets could be harmful, especially
over the longer term [9–11]. We therefore sought to determine
whether low CHO diets have any beneficial or harmful effects on
weight and cardiovascular risk factors when compared to balanced
diets.
What do existing systematic reviews say?
We first examined evidence from existing systematic reviews.
We sought any review that synthesised evidence on dietary
macronutrient manipulation and cardiovascular outcomes or risk
factors (last search: 3 March 2014). We found 50 reviews but these
had a number of methodological constraints precluding the
possibility that they could meaningfully address the question we
set out to answer (see Supporting Information S1 for detailed
summary). The main constraints were: they did not adequately
define the macronutrient composition of treatment and control
diets; the total energy intake in treatment and control diets was not
considered or was different between groups; arms included
additional interventions that could confound the findings, such
as exercise; inclusion of non-randomised studies and studies with
dissimilar follow-up periods (Table 1). In light of these shortcom-
ings, which make interpretation of the previous reviews problem-
atic, we carried out our own systematic review.
Macronutrient recommendations and low carbohydrate
diets
Nutrition specialists have defined ‘‘recommended, balanced
diets’’ in terms of macronutrient composition, micronutrients and
dietary quality to ensure adequate nutrition, energy balance for
health and weight maintenance, and prevention of NCDs in
healthy populations [12–15]. Recommended macronutrient rang-
es have been developed in the USA and Canada, Australia and
New Zealand and Europe [12–15] and are very similar across the
various countries and regions. For CHO, the recommended range
varies between 45 and 65% of total energy, for protein between 10
and 35% and for fat between 20 and 35%. Since not only quantity
(% contribution to total energy intake), but also quality (type and
nature) of macronutrients are important, guidance on the quality
aspects of CHO and fats are also included in most recommen-
dations [12–15]. Balanced weight loss diets restrict total energy
and adhere to the principles of a balance between energy derived
from CHO, protein and fat, as well as the recommended quality of
each macronutrient.
To further improve our understanding of these diets, we
examined and summarised the main themes in the advocacy
literature on low CHO diets and their supposed benefits. We
identified two main variants of low CHO diets. In Table 2, we
summarise examples of these, along with a balanced weight loss
diet, comparing key characteristics. Essentially, low CHO diets
emphasise a change in recommended macronutrient balance with
CHO restriction implemented by elimination or reduction of
specific foods and food groups and replacement of these with high
fat and protein foods. All restrict CHO intake, but the definitions
used for ‘low’ and the specific implementation, advice and health
claims provided with these diets vary. Very low CHO diets
advocate extreme restriction of CHO and are consequently high in
both protein and fat (which we have labelled high fat variant). A
second variant is also high in protein, but the amount of fat is
within recommended ranges and therefore restriction of CHO is
less extreme (labelled high protein variant). This information helped
to inform the protocol, specifically the sub-group analysis, for our
systematic review of relevant randomised controlled trials.
Objective
To compare the effects of low CHO and isoenergetic balanced
weight loss diets in overweight and obese adults.
Inclusion Criteria
Types of studies
We included randomised controlled trials (RCTs) in humans
published in English. Trials could be of a parallel or crossover
design, however, crossover trials were only included if first period
data could be extracted. We excluded trials with less than 10
participants randomised in each group.
Table 1. Main limitations identified in existing systematic reviews that served as constraints to interpretation of the evidence and
what we did to address them in our review.
What answering the research question
requires
Why was it identified as a limitation in existing
reviews?
What we did to address identified limitations
in our review
Explicit definition of treatment and control
diets with complete macronutrient profile
If unclear, any effects seen on weight loss and CVD
risk factors cannot be attributed to a well-defined
intervention diet compared to a well-defined control
diet
Used explicit cut-off ranges for macronutrients for
treatment and control diets; the complete
macronutrient profile of intervention diets had to
be available (proportions of total energy intake)
Recommended energy intake in treatment and
control groups needs to be similar
If different, any effects seen on weight loss and CVD risk
factors would be confounded by total energy intake
Only included isoenergetic diet comparisons
Co-interventions, such as drugs given as part of
the intervention, or recommendations for exercise,
need to be similar in the comparison groups
If different, any effects on CVD risk factors could be
confounded by co-interventions
Only included interventions with a diet component
alone, or combined interventions that were similar
to prevent confounding by co-interventions
Appropriate study design for the question Methodological heterogeneity: some reviews included
both controlled and uncontrolled trials
Only included randomised controlled trials
Meaningful and comparable follow-up in trials
needs to be considered
Outcomes of trials with different follow-ups were
pooled; generalised conclusions about weight loss
may be skewed by early changes; or follow-up may be
insufficient to detect CVD risk factor changes
Only included studies with 12 weeks or more
follow-up; and outcomes were grouped by defined
lengths of follow-up
CVD: cardiovascular disease.
Note: see Supporting Information S1 for the critical summary of existing systematic reviews.
doi:10.1371/journal.pone.0100652.t001
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Types of participants
People who are overweight or obese, have diabetes, glucose
intolerance or insulin resistance, cardiovascular conditions or risk
factors such as hypertension and dyslipidaemia, as defined by trial
authors. We excluded pregnant and lactating women and
individuals younger than 18 years.
Types of interventions
We required the studies to provide the macronutrient goals of
the diet in terms of their contribution to total energy intake, or that
these goals could be calculated as proportions of total energy
intake, for both the treatment and comparison arms. Treatment
diets were low CHO weight loss diet plans, including a) low CHO,
high fat, high protein diet (high fat variant) or b) low CHO,
recommended fat, high protein diet (high protein variant) (Table 3).
Control diets were balanced weight loss diet plans (Table 3) with
the same or similar prescribed energy content as the treatment
diet.
We excluded studies where: the treatment and control diets
were not adequately defined or where the control diet was defined
as ‘no dietary intervention’; diets were combined with any other
interventions (e.g. exercise, pharmacological, surgical) so that the
effect of diet alone could not be assessed; dietary interventions had
an exclusive focus on energy restriction, i.e. no macronutrient
manipulation was instituted; a substantial disparity in energy
intake (.500 kilojoules) between the prescribed treatment and
control diets was present; an ad libitum energy prescription was
used; interventions focused on specific foods, food groups or food
components (e.g. dairy, oats, plant sterols), meal replacement or
supplement products were used; the duration of the intervention
was less than 12 weeks or test meal responses (post-prandial) were
assessed.
Types of outcome measures
Weight. Total weight change (kg); body mass index (BMI)
(kg/m2).
Markers of cardiovascular disease risk. Diastolic blood
pressure (DBP) and systolic blood pressure (SBP) (mmHg); serum
cholesterol: low density lipoprotein (LDL), high density lipoprotein
(HDL) and total (mmol/L); serum triglycerides (TG) (mmol/L).
Table 2. Low carbohydrate (CHO) diets compared with a recommended, balanced weight loss diet.
Low CHO diet, high fat varianta
Low CHO diet, high protein
variantb Balanced weight loss diet
Examples Atkins diet [6,7] Zone diet [67,68] British Dietetic Association weight loss
plan [69]
Energy
Is energy explicitly restricted? No Noc Yes
Macronutrients
CHO Extreme restriction Moderate restriction 45–65% of total energy
Fat Unrestricted fat 25–35% of total energy 25–35% of total energy
Protein Unrestricted protein Promotes lean protein 10–20% of total energy
Quality
CHO Extreme restriction of all CHO food
sources
Extreme restriction of grains and
starches; fruit and vegetables
recommended
High fibre, unprocessed; promotion of
fruit, vegetables and legumes
Protein Unrestricted, especially animal protein Increased lean animal protein,
protein bars and shakes
Emphasis on plant protein and lean
animal protein
Fat Promotion of increased ‘natural’ fats,
including saturated (animal) fats
Promotion of monounsaturated
fats, mention of omega-3 fats
Promotion of polyunsaturated and
monounsaturated fats, replacement of
saturated fats with unsaturated fats,
avoidance of trans fats; adequate
omega-3 fats
Micronutrients
Is micronutrient intake addressed? Not specificallyd Not specificallye Not specificallyf
Selected claimed health benefits
Main Weight loss Weight loss Weight loss (if energy is restricted)
Other ‘‘Improvement in risk factors for heart
disease, hypertension and diabetes,
inflammation’’
‘‘Reverses cellular inflammation’’.
‘‘Cellular inflammation is what makes
us gain weight, accelerate the
development of chronic disease, and
decrease our physical performance’’
Reduces risk of obesity-related illness;
Reduces risk of non-communicable
diseases; Promotes nutritional adequacy
aEnergy reduction is implicit as a consequence of extreme restriction of carbohydrates, the reported satiating effect of protein, and appetite suppressing effect of
ketones.
bEnergy reduction is implicit as a consequence of extreme restriction of grains and starches and reported satiating effect of protein.
cPortion guides sometimes provided.
dPotential risks of inadequacies by extreme restriction of carbohydrates, including most vegetables and fruit.
ePotential risks of inadequacies by restricting grains and starches.
fPromoted indirectly through recommending a variety of foods from all food groups and quality food choices (including plenty of vegetables and fruit).
doi:10.1371/journal.pone.0100652.t002
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Table 3. Cut-off ranges* used to classify the macronutrient goals of treatment and control diets.
Classifications
Macronutrients Low Balanced High
Carbohydrate (% of total energy) ,45 45 to 65 .65
Fat (% of total energy) ,25 25 to 35 .35
Protein (% of total energy) ,10 10 to 20 .20
*Established by drawing on macronutrient recommendations from five global institutions and governments [12–15,70].
doi:10.1371/journal.pone.0100652.t003
Table 4. Search strategies for EMBASE.
Search: 22 October 2012
No. Query Results
#5 #3 AND #4 1312
#4 ‘randomised controlled trial’/exp OR ‘randomised controlled trial’ OR ‘randomised controlled trials’ OR ‘randomized
controlled trial’/exp OR ‘randomized controlled trial’ OR ‘randomized controlled trials’/exp OR ‘randomized controlled
trials’ AND [humans]/lim AND [english]/lim AND [embase]/lim AND [1-1-1966]/sd NOT [22-10-2012]/sd AND
[1966-2012]/py
249285
#3 #1 AND #2 2862
#2 ‘carbohydrate restricted diet’/exp OR ‘carbohydrate restricted diet’ OR ‘carbohydrate restricted diets’ OR ‘high fat diet’/exp
OR ‘high fat diet’ OR ‘high fat diets’ OR ‘fat restricted diet’/exp OR ‘fat restricted diet’ OR ‘fat restricted diets’ OR ‘ketogenic
diet’/exp OR ‘ketogenic diet’ OR ‘ketogenic diets’ AND [humans]/lim AND [english]/lim AND [embase]/lim AND
[1-1-1966]/sd NOT [22-10-2012]/sd AND [1966–2012]/py
11176
#1 ‘randomized controlled trial’/exp OR ‘randomized controlled trial’ OR random*:ab,ti OR trial:ti OR allocat*:ab,ti OR
factorial*:ab,ti OR placebo*:ab,ti OR assign*:ab,ti OR volunteer*:ab,ti OR ‘crossover procedure’/exp OR ‘crossover
procedure’ OR ‘double-blind procedure’/exp OR ‘double-blind procedure’ OR ‘single-blind procedure’/exp OR
‘single-blind procedure’ OR (doubl* NEAR/3 blind*):ab,ti OR (singl*:ab,ti AND blind*:ab,ti) OR crossover*:ab,ti OR
cross+over*:ab,ti OR (cross NEXT/1 over*):ab,ti AND [humans]/lim AND [english]/lim AND [embase]/lim AND [1-1-1966]/sd
NOT [22-10-2012]/sd AND [1966–2012]/py
879594
Updated search: 5 June 2013
#5 #3 AND #4 80
#4 ‘randomised controlled trial’/exp OR ‘randomised controlled trials’ OR ‘randomized controlled trial’/exp OR ‘randomized
controlled trials’/exp AND [humans]/lim AND [english]/lim AND [embase]/lim AND [23-10-2012]/sd NOT [6-6-2013]/sd
20424
#3 #1 AND #2 236
#2 ‘carbohydrate restricted diet’/exp OR ‘carbohydrate restricted diets’ OR ‘high fat diet’/exp OR ‘high fat diets’ OR ‘fat
restricted diet’/exp OR ‘fat restricted diets’ OR ‘ketogenic diet’/exp OR ‘ketogenic diets’ AND [humans]/lim AND
[english]/lim AND [embase]/lim AND [23-10-2012]/sd NOT [6-6-2013]/sd
1005
#1 ‘randomized controlled trial’/exp OR random*:ab,ti OR trial:ti OR allocat*:ab,ti OR factorial*:ab,ti OR placebo*:ab,ti OR
assign*:ab,ti OR volunteer*:ab,ti OR ‘crossover procedure’/exp OR ‘double-blind procedure’/exp OR ‘single-blind
procedure’/exp OR (doubl* NEAR/3 blind*):ab,ti OR (singl*:ab,ti AND blind*:ab,ti) OR crossover*:ab,ti OR cross+over*:
ab,ti OR (cross NEXT/1 over*):ab,ti AND [humans]/lim AND [english]/lim AND [embase]/lim AND [23-10-2012]/sd NOT
[6-6-2013]/sd
73855
Updated search: 19 March 2014
#5 #3 AND #4 145
#4 ‘randomised controlled trial’/exp OR ‘randomised controlled trial’ OR ‘randomised controlled trials’ OR ‘randomized
controlled trial’/exp OR ‘randomized controlled trial’ OR ‘randomized controlled trials’/exp OR ‘randomized controlled
trials’ AND [humans]/lim AND [english]/lim AND [embase]/lim AND [7-6-2013]/sd NOT [18-3-2014]/sd
29989
#3 #1 AND #2 384
#2 ‘carbohydrate restricted diet’/exp OR ‘carbohydrate restricted diet’ OR ‘carbohydrate restricted diets’ OR ‘high fat
diet’/exp OR ‘high fat diet’ OR ‘high fat diets’ OR ‘fat restricted diet’/exp OR ‘fat restricted diet’ OR ‘fat restricted
diets’ OR ‘ketogenic diet’/exp OR ‘ketogenic diet’ OR ‘ketogenic diets’ AND [humans]/lim AND [english]/lim AND
[embase]/lim AND [7-6-2013]/sd NOT [18-3-2014]/sd
1731
#1 ‘randomized controlled trial’/exp OR ‘randomized controlled trial’ OR random*:ab,ti OR trial:ti OR allocat*:ab,ti OR
factorial*:ab,ti OR placebo*:ab,ti OR assign*:ab,ti OR volunteer*:ab,ti OR ‘crossover procedure’/exp OR ‘crossover
procedure’ OR ‘double-blind procedure’/exp OR ‘double-blind procedure’ OR ‘single-blind procedure’/exp OR
‘single-blind procedure’ OR (doubl* NEAR/3 blind*):ab,ti OR (singl*:ab,ti AND blind*:ab,ti) OR crossover*:ab,ti OR
cross+over*:ab,ti OR (cross NEXT/1 over*):ab,ti AND [humans]/lim AND [english]/lim AND [embase]/lim AND
[7-6-2013]/sd NOT [18-3-2014]/sd
108635
doi:10.1371/journal.pone.0100652.t004
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Markers of diabetes mellitus risk or glycaemic
control. Glycosylated haemoglobin (HbA1c) (%); fasting blood
glucose (FBG) (mmol/L).
Mortality, myocardial infarction and stroke were not explicitly
excluded as outcomes, but we did not expect to find randomised
controlled trials with these outcomes where dietary manipulations
were under study.
Search Methods for Identification of Studies
Electronic searches were done in MEDLINE via PubMed,
Excerpta Medica Database (EMBASE) and The Cochrane Central
Register of Clinical Trials (CENTRAL), with the last search on 19
March 2014. The full electronic search strategy for EMBASE is
detailed in Table 4. In addition, the references of the previously
mentioned 50 existing systematic reviews were searched.
Data Collection and Analysis
Selection of studies
Two authors (CN and AS) screened titles and abstracts of all
search results and identified potentially eligible studies using the
pre-specified eligibility criteria. Full text articles for these studies
were obtained and assessed by the two authors simultaneously.
Studies not fulfilling eligibility criteria were excluded with reasons.
All discrepancies were resolved by consensus.
Data extraction and management
Two authors (CN and AS) extracted data using an electronic
data extraction spreadsheet in Microsoft Excel. The main sections
of the spreadsheet included information on the design, country,
participants, treatment, control, diet quality, energy and nutrient
composition, adherence, outcomes and results, funding, conflict of
interest, and risk of bias. The extracted data were collated in tables
Figure 1. Flow diagram illustrating the search results and selection process, as well as the variants of the low carbohydrate diets
used as treatments in the included trials. The high fat variant of low carbohydrate diets is low in carbohydrates (,45% of total energy), high in
fat (.35% of total energy) and high in protein (.20% of total energy). The high protein variant of low carbohydrate diets is low in carbohydrates (,
45% of total energy), has a recommended proportion of fat (20 to 35% of total energy) and is high in protein (.20% of total energy).
doi:10.1371/journal.pone.0100652.g001
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and figures. The author of one included RCT [16] was contacted
and provided means and standard deviations that could not be
read accurately from a figure in the publication.
Length of follow-up
Outcomes were grouped into those measured between baseline
and three to six months of follow-up; and between baseline and
one to two years of follow-up. For trials measuring outcomes at
several time points within either of these two categories, we took
the values for the longest follow-up within that category (for
example, where results were available at three and six months, the
results at six months were used).
Risk of bias assessment
Two authors (CN and AS) assessed the risk of bias in the
included studies by using the Cochrane Collaboration risk of bias
tool [17], where domains include random sequence generation,
allocation concealment, performance and detection bias, attrition
bias, reporting bias and ‘other’ bias. Criteria for low risk, high risk
and unclear risk of bias per the Cochrane Handbook for
Systematic Reviews of Interventions [17] were used.
Adherence
For energy, the prescribed and reported total energy intakes
(kilojoules) for each reported follow-up category in the trial were
tabulated per group, as were group comparisons of mean reported
energy intake reported by trial authors. For macronutrients,
adherence was calculated as the difference between the reported
mean and prescribed distribution of energy intake (% of total
energy) from CHO, fat and protein for each follow-up category.
For trials reporting dietary intake at several time points within
either of the two follow-up categories, we took the values for the
longest follow-up within that category. Specifically, adherence was
calculated using a Mahalanobis distance equation, which can be
used to measure the similarity between a set of actual conditions
relative to a set of ideal conditions [18]. The equation generated
an adherence score that represents the degree of deviation from
the prescribed goals for macronutrients in the treatment and
control groups. A lower score reflects better adherence and a
higher score reflects poorer adherence.
The equation for the macronutrient adherence score, where TE
is total energy:
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
mean reported % carbohydrate of TE{prescribed goal % carbohydrate of TEð Þ2z
mean reported % fat of TE{prescribed goal % fat of TEð Þ2z
mean reported % protein of TE{prescribred goal % protein of TEð Þ2
vuuuut
Measures of treatment effect
Review Manager (RevMan) 5.2 was used to manage the
extracted data and to conduct meta-analyses [19] for each
outcome, where relevant, to determine a pooled effect of low
CHO diets compared to balanced diets. Mean differences (MD)
were calculated for continuous data and reported alongside 95%
confidence intervals (CIs). Where change per group was not
available, end values were used and we combined change from
baseline results with end values [17]. Footnotes on the figures of
forest plots indicate when end values were used.
Unit of analysis issues
No crossover trials met the inclusion criteria. In the case of
multiple intervention groups, we selected one pair of interventions
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i.e. treatment and control that was most relevant to this systematic
review question [17].
Assessment of heterogeneity
Statistical heterogeneity was assessed with the Chi2 test
(significance level p ,0.1) and quantified with the I2 test [20]
where I2 values of 50% or more indicate a substantial level of
heterogeneity and values of 75% or more indicate considerable
heterogeneity [17].
Assessment of reporting bias
We assessed reporting bias with funnel plots when we had 10 or
more studies per outcome, which was the case for five outcomes in
non-diabetic overweight and obese adults in the early follow-up
category.
Data synthesis and investigation of heterogeneity
The outcomes were reported as the difference in the mean
change between the treatment and control groups. Because the
presence of diabetes is likely to influence the effects of the diet, we
stratified by trials of overweight and obese participants without
and with type 2 diabetes. Heterogeneity between the included
studies was anticipated due to variations in dietary plans and goals,
length of follow-up and dietary methodology, and the random-
effects model was therefore used for all meta-analyses. We
stratified the analysis by whether the treatment group was the
high fat variant or the high protein variant of low CHO diets, and
pooled the estimate if there was no obvious heterogeneity.
GRADE analysis
We assessed the quality of evidence using GradePro (Grade
Profiler) 3.2.2 software [21,22]. We used standard terms to
translate the quality of the evidence, as assessed by GRADE, into
words to express the quality of evidence and magnitude of effect.
For example, for large effects and moderate quality evidence, we
use the word ‘‘probably’’, whereas for low quality we use the word
‘‘may’’ [23].
Results
Description of studies
Results of the search and included studies. We screened
3450 records and retrieved and screened 179 full-text articles, after
which we included 19 RCTs (Figure 1). We included 19 RCTs
with 3209 participants [16,24–41]. All trials used a parallel group
design, were published after 2001 and were conducted in high-
income countries (United States of America (5), Australia (7), New
Zealand (1), Germany (1), Norway (1), United Kingdom (1),
Sweden (1) and Spain (2)). Sample size varied between 25 and 402
participants. Follow-up ranged from 12 weeks to two years.
There were 14 trials in people without diabetes [16,24,26–
29,31–33,36–39,41] and five trials in people with type 2 diabetes
mellitus [25,30,34,35,40]. Nine trials tested the high fat variant of
the low CHO diet and 10 trials tested the high protein variant.
Figure 1 displays the number of trials and variants of the low CHO
diet used as treatments in each population. In people without
diabetes, eight trials examined the high fat variant
[16,24,26,27,29,32,33,38] and 6 the high protein variant
[28,31,36,37,39,41]. A single trial [30] evaluated the high fat
variant and four [25,34,35,40] evaluated the high protein variant
in adults with type 2 diabetes mellitus. No included trials reported
mortality, myocardial infarction or stroke as outcomes.
Two trials were only in men [33,41] and the rest were mixed.
All trials included only participants who were overweight or obese
(BMI of 26 kg/m2 or greater). In all trials that reported baseline
BMIs, the mean baseline BMI in both groups was greater than
30 kg/m2. The WHO classifies an individual as overweight when
their BMI is greater than or equal to 25 kg/m2 and as obese when
BMI is greater than or equal to 30 kg/m2 [42]. Table 5 provides
Table 7. Excluded studies and reasons for exclusion.
Reasons for exclusion Number of studies excluded
Not a randomised controlled trial 4 [71–74]
Duration of the intervention ,12 weeks 40 [75–114]
All three macronutrients not prescribed (or cannot be calculated as proportions of the total energy intake) 20 [115–134]
Non-English language 1 [135]
Test meal response measured 1 [136]
Meal replacement 2 [137,138]
Combined interventions were involved 3 [139–141]
Treatment and control both low carbohydrate – not an eligible comparison 3 [142–144]
Comparison not meaningful (carbohydrate content of treatment and controls differ ,5% of TE) 2 [145,146]
No eligible balanced carbohydrate control 1 [147]
Crossover trial where first period data cannot be extracted: 1 1 [148]
Substantial disparity in energy intake between prescribed intervention diets 13 [49,51,149–159]
Treatment diet is not low in carbohydrates 26 [160–185]
Control diet is not within balanced macronutrient range 4 [186–189]
Duplicate and/or complimentary 24 [190–213]
Energy intake ad libitum 8 [214–221]
Ineligible low carbohydrate diet variant 6 [222–227]
Less than 10 participants randomised per group 1 [228]
RCT = randomised controlled trial; CHO= carbohydrate.
doi:10.1371/journal.pone.0100652.t007
Low Carbohydrate versus Balanced Diets for Reducing Weight
PLOS ONE | www.plosone.org 9 July 2014 | Volume 9 | Issue 7 | e100652
T
a
b
le
8
.
R
is
k
o
f
b
ia
s
in
o
ve
rw
e
ig
h
t
an
d
o
b
e
se
ad
u
lt
p
o
p
u
la
ti
o
n
.
F
ir
st
a
u
th
o
r
Y
e
a
r
p
u
b
li
sh
e
d
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
Ju
d
g
e
m
e
n
t
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
C
o
m
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
Ju
d
g
e
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
C
o
m
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
Ju
d
g
e
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
C
o
m
m
e
n
t
D
e
te
ct
io
n
b
ia
s
Ju
d
g
e
m
e
n
t
D
e
te
ct
io
n
b
ia
s
C
o
m
m
e
n
t
A
tt
ri
ti
o
n
b
ia
s
Ju
d
g
e
m
e
n
t
A
tt
ri
ti
o
n
*
b
ia
s
C
o
m
m
e
n
t
(R
x
/C
o
n
tr
o
l
g
ro
u
p
)
R
e
p
o
rt
in
g
b
ia
s
Ju
d
g
e
m
e
n
t
R
e
p
o
rt
in
g
b
ia
s
C
o
m
m
e
n
t
O
th
e
r
b
ia
s
Ju
d
g
em
en
t
O
th
e
r
b
ia
s
C
o
m
m
e
n
t
O
v
e
rw
e
ig
h
t
a
n
d
o
b
e
se
a
d
u
lt
s
A
u
d
e
[2
4
]
2
0
0
4
Lo
w
ri
sk
B
lo
ck
d
e
si
g
n
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
Lo
w
ri
sk
A
ss
e
ss
o
rs
b
lin
d
e
d
H
ig
h
ri
sk
3
%
/1
7
%
at
tr
it
io
n
(d
if
fe
re
n
ti
al
),
n
o
re
as
o
n
s
Lo
w
ri
sk
P
ro
to
co
l
n
o
t
av
ai
la
b
le
,
b
u
t
p
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
H
ig
h
ri
sk
Fo
o
d
ch
o
ic
e
ad
vi
ce
&
fi
b
re
su
p
p
le
m
e
n
ts
o
n
ly
g
iv
e
n
to
R
x
g
ro
u
p
D
e
Lu
is
[2
7
]
2
0
0
9
Lo
w
ri
sk
R
an
d
o
m
n
u
m
b
e
r
lis
t
U
n
cl
e
ar
ri
sk
‘‘c
lo
se
d
e
n
ve
lo
p
e
’’
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
Lo
w
ri
sk
N
o
at
tr
it
io
n
Lo
w
ri
sk
P
ro
to
co
l
n
o
t
av
ai
la
b
le
,
b
u
t
p
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
H
ig
h
ri
sk
Fu
n
d
in
g
&
C
O
I
N
R
,
im
b
al
an
ce
d
b
as
e
lin
e
D
B
P
,
H
D
L,
T
G
D
e
Lu
is
[2
6
]
2
0
1
2
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
Lo
w
ri
sk
N
o
at
tr
it
io
n
H
ig
h
ri
sk
N
o
p
re
sp
e
ci
fi
e
d
o
u
tc
o
m
e
s,
p
ro
to
co
l
n
o
t
av
ai
la
b
le
H
ig
h
ri
sk
Fu
n
d
in
g
&
C
O
I
N
R
,
im
b
al
an
ce
d
b
as
e
lin
e
SB
P
,
H
D
L
Fa
rn
sw
o
rt
h
[2
8]
2
0
0
3
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
1
4
%
to
ta
l
at
tr
it
io
n
,
at
tr
it
io
n
&
re
as
o
n
s
n
o
t
p
ro
vi
d
e
d
p
e
r
g
ro
u
p
H
ig
h
ri
sk
N
o
p
re
sp
e
ci
fi
e
d
o
u
tc
o
m
e
s,
p
ro
to
co
l
n
o
t
av
ai
la
b
le
U
n
cl
e
ar
ri
sk
Fu
n
d
in
g
:
p
o
ss
ib
le
in
fl
u
e
n
ce
s
Fr
is
ch
[2
9
]
2
0
0
9
Lo
w
ri
sk
C
o
m
p
u
te
r
g
e
n
e
ra
te
d
ra
n
d
o
m
n
o
.
lis
ts
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
Lo
w
ri
sk
IT
T
an
al
ys
is
Lo
w
ri
sk
P
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
,
p
ro
to
co
l
av
ai
la
b
le
Lo
w
ri
sk
-
Low Carbohydrate versus Balanced Diets for Reducing Weight
PLOS ONE | www.plosone.org 10 July 2014 | Volume 9 | Issue 7 | e100652
T
a
b
le
8
.
C
o
n
t.
F
ir
st
a
u
th
o
r
Y
e
a
r
p
u
b
li
sh
e
d
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
Ju
d
g
e
m
e
n
t
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
C
o
m
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
Ju
d
g
e
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
C
o
m
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
Ju
d
g
e
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
C
o
m
m
e
n
t
D
e
te
ct
io
n
b
ia
s
Ju
d
g
e
m
e
n
t
D
e
te
ct
io
n
b
ia
s
C
o
m
m
e
n
t
A
tt
ri
ti
o
n
b
ia
s
Ju
d
g
e
m
e
n
t
A
tt
ri
ti
o
n
*
b
ia
s
C
o
m
m
e
n
t
(R
x
/C
o
n
tr
o
l
g
ro
u
p
)
R
e
p
o
rt
in
g
b
ia
s
Ju
d
g
e
m
e
n
t
R
e
p
o
rt
in
g
b
ia
s
C
o
m
m
e
n
t
O
th
e
r
b
ia
s
Ju
d
g
em
en
t
O
th
e
r
b
ia
s
C
o
m
m
e
n
t
K
e
o
g
h
[3
1
]
2
0
0
8
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
3
6
%
to
ta
l
at
tr
it
io
n
,
at
tr
it
io
n
&
re
as
o
n
s
n
o
t
p
ro
vi
d
e
d
p
e
r
g
ro
u
p
Lo
w
ri
sk
P
re
sp
e
ci
fi
e
d
an
d
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
,
p
ro
to
co
l
av
ai
la
b
le
H
ig
h
ri
sk
In
co
m
p
le
te
an
d
su
sp
e
ct
e
d
e
rr
o
rs
in
re
p
o
rt
in
g
,
im
b
al
an
ce
d
b
as
e
lin
e
T
G
K
le
m
sd
al
[3
2
]
2
0
1
0
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
Lo
w
ri
sk
IT
T
an
al
ys
is
Lo
w
ri
sk
P
re
sp
e
ci
fi
e
d
an
d
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
,
p
ro
to
co
l
av
ai
la
b
le
U
n
cl
e
ar
ri
sk
C
O
I
N
R
K
ra
u
ss
[3
3
]
2
0
0
6
Lo
w
ri
sk
B
lo
ck
s
o
f
4
,
8
,
1
2
,
1
6
,
2
0
,
2
4
U
n
cl
e
ar
ri
sk
Se
al
e
d
se
q
u
e
n
ti
al
ly
n
o
.
e
n
ve
lo
p
e
s,
n
o
t
o
p
aq
u
e
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
2
3
/1
4
%
at
tr
it
io
n
(d
if
fe
re
n
ti
al
),
re
as
o
n
s
n
o
t
p
e
r
g
ro
u
p
H
ig
h
ri
sk
O
n
ly
1
o
u
tc
o
m
e
p
re
sp
e
ci
fi
e
d
,
p
ro
to
co
l
n
o
t
av
ai
la
b
le
U
n
cl
e
ar
ri
sk
C
O
I
N
R
La
sk
e
r
[3
6
]
2
0
0
8
Lo
w
ri
sk
B
lo
ck
ra
n
d
o
m
is
at
io
n
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
2
2
/2
4
%
at
tr
it
io
n
,
n
o
re
as
o
n
s
Lo
w
ri
sk
P
ro
to
co
l
n
o
t
av
ai
la
b
le
,
b
u
t
p
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
H
ig
h
ri
sk
Fu
n
d
in
g
:
p
o
ss
ib
le
in
fl
u
e
n
ce
s
La
ym
an
[3
7
]
2
0
0
9
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
3
6
/5
5
%
at
tr
it
io
n
(d
if
fe
re
n
ti
al
),
re
as
o
n
s
d
if
fe
r
p
e
r
g
ro
u
p
Lo
w
ri
sk
P
ro
to
co
l
n
o
t
av
ai
la
b
le
,
b
u
t
p
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
U
n
cl
e
ar
ri
sk
Fu
n
d
in
g
an
d
C
O
I
re
p
o
rt
e
d
:
p
o
ss
ib
le
in
fl
u
e
n
ce
s
Li
m
[3
8
]
2
0
1
0
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
4
3
/5
0
%
at
tr
it
io
n
,
re
as
o
n
s
d
if
fe
r
p
e
r
g
ro
u
p
(d
if
fe
re
n
ti
al
)
Lo
w
ri
sk
P
ro
to
co
l
n
o
t
av
ai
la
b
le
,
b
u
t
p
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
Lo
w
ri
sk
-
Low Carbohydrate versus Balanced Diets for Reducing Weight
PLOS ONE | www.plosone.org 11 July 2014 | Volume 9 | Issue 7 | e100652
T
a
b
le
8
.
C
o
n
t.
F
ir
st
a
u
th
o
r
Y
e
a
r
p
u
b
li
sh
e
d
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
Ju
d
g
e
m
e
n
t
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
C
o
m
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
Ju
d
g
e
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
C
o
m
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
Ju
d
g
e
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
C
o
m
m
e
n
t
D
e
te
ct
io
n
b
ia
s
Ju
d
g
e
m
e
n
t
D
e
te
ct
io
n
b
ia
s
C
o
m
m
e
n
t
A
tt
ri
ti
o
n
b
ia
s
Ju
d
g
e
m
e
n
t
A
tt
ri
ti
o
n
*
b
ia
s
C
o
m
m
e
n
t
(R
x
/C
o
n
tr
o
l
g
ro
u
p
)
R
e
p
o
rt
in
g
b
ia
s
Ju
d
g
e
m
e
n
t
R
e
p
o
rt
in
g
b
ia
s
C
o
m
m
e
n
t
O
th
e
r
b
ia
s
Ju
d
g
em
en
t
O
th
e
r
b
ia
s
C
o
m
m
e
n
t
Lu
sc
o
m
b
e
[3
9
]
2
0
0
3
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
Lo
w
ri
sk
N
o
at
tr
it
io
n
H
ig
h
ri
sk
N
o
p
re
sp
e
ci
fi
e
d
o
u
tc
o
m
e
s,
p
ro
to
co
l
n
o
t
av
ai
la
b
le
U
n
cl
e
ar
ri
sk
C
O
I
N
R
;
Fu
n
d
in
g
:
p
o
ss
ib
le
in
fl
u
e
n
ce
s
Sa
ck
s
[1
6
]
2
0
0
9
U
n
cl
e
ar
ri
sk
N
R
Lo
w
ri
sk
C
e
n
tr
al
ly
Lo
w
ri
sk
P
ar
ti
ci
p
an
ts
b
lin
d
e
d
Lo
w
ri
sk
A
ss
e
ss
o
rs
b
lin
d
e
d
Lo
w
ri
sk
IT
T
Lo
w
ri
sk
P
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
,
p
ro
to
co
l
av
ai
la
b
le
Lo
w
ri
sk
-
W
yc
h
e
rl
e
y
[4
1
]
2
0
1
2
Lo
w
ri
sk
C
o
m
p
u
te
r
g
e
n
e
ra
te
d
ra
n
d
o
m
n
o
.
lis
ts
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
4
4
/4
5
%
at
tr
it
io
n
U
n
cl
e
ar
ri
sk
P
ro
to
co
l
re
tr
o
sp
e
ct
iv
e
ly
re
g
is
te
re
d
,
o
u
tc
o
m
e
s
o
n
ly
sp
e
ci
fi
e
d
in
ab
st
ra
ct
,
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
H
ig
h
ri
sk
Fu
n
d
in
g
:
p
o
ss
ib
le
in
fl
u
e
n
ce
,
an
al
ys
is
at 1
2
w
e
e
ks
o
n
ly
in
cl
u
d
e
d
d
at
a
fr
o
m
5
2
w
e
e
k
co
m
p
le
te
rs
b
u
t
d
ro
p
o
u
ts
af
te
r
1
2
w
e
e
ks
lo
st
le
ss
w
e
ig
h
t
O
v
e
rw
e
ig
h
t
a
n
d
o
b
e
se
a
d
u
lt
s
w
it
h
T
y
p
e
2
d
ia
b
e
te
s
m
e
ll
it
u
s
B
ri
n
kw
o
rt
h
[2
5
]
2
0
0
4
Lo
w
ri
sk
R
an
d
o
m
n
o
.
g
e
n
e
ra
to
r
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
4
2
/4
2
%
at
tr
it
io
n
,
re
as
o
n
s
d
if
fe
r
p
e
r
g
ro
u
p
Lo
w
ri
sk
P
ro
to
co
l
n
o
t
av
ai
la
b
le
,
b
u
t
p
re
sp
e
ci
fi
e
d
an
d
al
l
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
H
ig
h
ri
sk
Im
b
al
an
ce
d
b
as
e
lin
e
w
e
ig
h
t,
D
B
P
,
SB
P
g
lu
co
se
G
u
ld
b
ra
n
d
[3
0
]
2
0
1
2
Lo
w
ri
sk
D
ra
w
in
g
b
lin
d
e
d
b
al
lo
ts
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
Lo
w
ri
sk
N
o
at
tr
it
io
n
H
ig
h
ri
sk
P
ro
to
co
l
av
ai
la
b
le
:
p
re
sp
e
ci
fi
e
d
o
u
tc
o
m
e
s
va
g
u
e
H
ig
h
ri
sk
Im
b
al
an
ce
d
b
as
e
lin
e
w
e
ig
h
t
&
B
M
I
Low Carbohydrate versus Balanced Diets for Reducing Weight
PLOS ONE | www.plosone.org 12 July 2014 | Volume 9 | Issue 7 | e100652
T
a
b
le
8
.
C
o
n
t.
F
ir
st
a
u
th
o
r
Y
e
a
r
p
u
b
li
sh
e
d
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
Ju
d
g
e
m
e
n
t
R
a
n
d
o
m
se
q
u
e
n
ce
g
e
n
e
ra
ti
o
n
C
o
m
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
Ju
d
g
e
m
e
n
t
A
ll
o
ca
ti
o
n
co
n
ce
a
lm
e
n
t
C
o
m
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
Ju
d
g
e
m
e
n
t
P
e
rf
o
rm
a
n
ce
b
ia
s
C
o
m
m
e
n
t
D
e
te
ct
io
n
b
ia
s
Ju
d
g
e
m
e
n
t
D
e
te
ct
io
n
b
ia
s
C
o
m
m
e
n
t
A
tt
ri
ti
o
n
b
ia
s
Ju
d
g
e
m
e
n
t
A
tt
ri
ti
o
n
*
b
ia
s
C
o
m
m
e
n
t
(R
x
/C
o
n
tr
o
l
g
ro
u
p
)
R
e
p
o
rt
in
g
b
ia
s
Ju
d
g
e
m
e
n
t
R
e
p
o
rt
in
g
b
ia
s
C
o
m
m
e
n
t
O
th
e
r
b
ia
s
Ju
d
g
em
en
t
O
th
e
r
b
ia
s
C
o
m
m
e
n
t
K
re
b
s
[3
4
]
2
0
1
2
Lo
w
ri
sk
C
o
m
p
u
te
r
g
e
n
e
ra
te
d
ra
n
d
o
m
n
o
.
Lo
w
ri
sk
In
d
e
p
e
n
d
e
n
t
b
io
st
at
is
ti
ci
an
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
H
ig
h
ri
sk
3
0
/2
9
%
,
re
as
o
n
s
d
if
fe
r
p
e
r
g
ro
u
p
(d
if
fe
re
n
ti
al
)
Lo
w
ri
sk
P
re
sp
e
ci
fi
e
d
an
d
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
,
p
ro
to
co
l
av
ai
la
b
le
Lo
w
ri
sk
-
La
rs
e
n
[3
5
]
2
0
1
1
Lo
w
ri
sk
R
an
d
o
m
b
lo
ck
si
ze
s
Lo
w
ri
sk
C
e
n
tr
al
ly
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
Lo
w
ri
sk
A
ss
e
ss
o
rs
b
lin
d
e
d
H
ig
h
ri
sk
1
6
/1
2
%
at
tr
it
io
n
,
re
as
o
n
s
d
if
fe
r
p
e
r
g
ro
u
p
(d
if
fe
re
n
ti
al
)
LO
C
F
an
al
ys
is
o
n
ly
o
n
so
m
e
m
is
si
n
g
p
ar
ti
ci
p
an
ts
Lo
w
ri
sk
P
re
sp
e
ci
fi
e
d
an
d
N
B
o
u
tc
o
m
e
s
ad
d
re
ss
e
d
,
p
ro
to
co
l
av
ai
la
b
le
U
n
cl
e
ar
ri
sk
C
O
I:
N
R
P
ar
ke
r
[4
0
]
2
0
0
2
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
N
R
U
n
cl
e
ar
ri
sk
Eq
u
al
co
n
ta
ct
ti
m
e
b
u
t
n
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
N
o
t
b
lin
d
e
d
U
n
cl
e
ar
ri
sk
1
9
/1
8
%
at
tr
it
io
n
,
n
o
re
as
o
n
s
H
ig
h
ri
sk
N
o
p
re
sp
e
ci
fi
e
d
o
u
tc
o
m
e
s,
p
ro
to
co
l
n
o
t
av
ai
la
b
le
H
ig
h
ri
sk
C
O
I
N
R
;
Fu
n
d
in
g
:
p
o
ss
ib
le
in
fl
u
e
n
ce
s;
im
b
al
an
ce
d
b
as
e
lin
e
w
e
ig
h
t
&
g
lu
co
se
*n
u
m
b
e
r
o
f
at
tr
it
io
n
p
e
r
g
ro
u
p
g
iv
e
n
fo
r
lo
n
g
e
st
fo
llo
w
-u
p
w
it
h
in
th
e
ca
te
g
o
ri
e
s;
B
M
I=
b
o
d
y
m
as
s
in
d
e
x;
B
P
=
b
lo
o
d
p
re
ss
u
re
s;
C
O
I=
co
n
fl
ic
t
o
f
in
te
re
st
;
D
B
P
=
d
ia
st
o
lic
b
lo
o
d
p
re
ss
u
re
;
H
D
L
=
h
ig
h
d
e
n
si
ty
lip
o
p
ro
te
in
ch
o
le
st
e
ro
l;
IT
T
=
in
te
n
ti
o
n
-t
o
-t
re
at
;
LO
C
F:
La
st
o
b
se
rv
at
io
n
ca
rr
ie
d
fo
rw
ar
d
;
N
B
=
im
p
o
rt
an
t;
N
o
=
n
u
m
b
e
r;
N
R
=
N
o
t
re
p
o
rt
e
d
;
R
x
=
tr
e
at
m
e
n
t;
T
G
=
tr
ig
ly
ce
ri
d
e
s.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
1
0
0
6
5
2
.t
0
0
8
Low Carbohydrate versus Balanced Diets for Reducing Weight
PLOS ONE | www.plosone.org 13 July 2014 | Volume 9 | Issue 7 | e100652
characteristics of included trials per population group and Table 6,
the prescribed dietary goals for the treatment and control diets per
included trial and population group. We excluded 160 full-text
articles with reason given in Table 7; the most common reason was
follow-up less than 12 weeks.
Risk of bias in included studies. Risk of bias is reported in
Table 8 and displayed in Figure 2.
Generation of sequence and allocation concealment: Ten trials reported
the method of randomisation; three trials reported adequate
concealment and in the rest it was unclear.
Blinding: Blinding of participants in diet trials is not easy as they
usually have to follow specific dietary plans in order to attain the
prescribed goals of the intervention diets. Three trials blinded the
outcome assessors of which one also reported blinding the
participants.
Incomplete outcome data: After 3–6 months, reported loss to follow-
up ranged from no loss to 42%, peaking at 47% after 15 months in
one of the trials. Ten trials had overall attrition greater than 20%,
differential attrition between groups, or both. Six trials had
differential loss and/or different or unspecified reasons for loss to
follow-up. Seven trials had low risk of attrition bias, with four
reporting no attrition and three performing intention-to-treat
analysis.
Selective reporting: Six trials did not have protocols available or
outcomes were not pre-specified in the methods section of the trial
reports and one trial had an unclear risk of reporting bias. The
remaining 12 trials were judged to have low risk of reporting bias.
Publication bias: Assessment of the funnel plot asymmetry for the
five outcomes in overweight and obese adults in the early follow-
up category showed that for weight loss, small studies with a
negative mean difference are missing. Similarly, smaller studies
appear to be missing for the other four outcomes, namely serum
LDL, HDL and total cholesterol, and serum triglycerides (data not
shown).
Other potential sources of bias: Nine trials were judged to have a high
risk of other types of bias. Six trials were funded independently,
five were funded by industry, five by a combination of
independent and industry funding and the remaining three trials
did not report their funding source. Four trials had low risk of
other bias.
Adherence to prescribed dietary goals. Table 9 shows the
energy prescriptions, the mean reported total energy intakes and
the calculated adherence scores for macronutrients for all lengths
of follow-up per diet group (see Table 6 for the prescribed dietary
goals for the treatment and control diets per included trial). Energy
prescriptions for the weight loss diets were expressed as absolute
goals or ranges, or as absolute or percentage deficits, with some
trials using sex-specific goals. In the 12 trials that reported group
comparisons in energy intake, only one found a difference, with a
lower reported intake in the balanced diet group [34] (Table 9).
None of these 12 trials demonstrated a difference in weight loss
between the low CHO and balanced diet groups at any follow-up
category.
Thirteen and eight trials reported mean CHO, fat and protein
intakes at 3–6 months and 1–2 years, respectively (Table 9).
Calculated adherence scores were variable across the two diet
groups and follow-up categories. Four trials showed similar
adherence (difference in scores between groups ,1) to prescribed
macronutrient goals in the two diet groups after 3–6 month follow-
up [16,29–31]. Five trials showed better adherence in the low
CHO diet groups [35–37,40,41] and four trials showed better
adherence in the balanced diet group [28,34,38,39]. At 1–2 years
follow-up, there were greater discrepancies in the adherence scores
between the two diet groups. The low CHO diet group showed
better adherence to macronutrient prescriptions in three trials
[16,35,41] and the balanced diet group showed better adherence
in five trials [29,30,34,37,38] (Table 9).
Effects of interventions
The effect estimates between the two dietary variants (high fat
and high protein) did not show a qualitative difference and the
heterogeneity between the groups was small or not detectable, so
we pooled data across the two low CHO diet variants in the
analysis.
Trials in participants without type 2 diabetes
Total weight loss. At 3–6 months, the average weight loss in
trials in the low CHO group ranged from 2.65 to 10.2 kg and in
the isoenergetic balanced diet group from 2.65 to 9.4 kg. At 1–2
years, the range of weight loss was 2.9 to 12.3 kg with low CHO
diets and 3.5 to 10.9 kg with isoenergetic balanced diets.
The meta-analysis of the mean difference in weight loss between
the low CHO and balanced diets did not demonstrate a difference
at 3–6 months (20.74 kg, 95%CI 21.49 to 0.01; 14 trials)
(Table 10; Figure 3); and at 1–2 years (20.48 kg, 95%CI 21.44 to
0.49; 7 trials) (Table 11; Figure 4). In the study [16] that concealed
allocation, there was no mean difference in weight loss at 3–6
months (0.20 kg, 95%CI 20.88 to 1.28; n= 402) and at 1–2 years
(0.60 kg, 95%CI 20.76 to 1.96).
Figure 2. Risk of bias: systematic review authors’ judgements about each risk of bias item presented as percentages across all
included trials using the Cochrane risk of bias tool (n=19).
doi:10.1371/journal.pone.0100652.g002
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A few studies reported change in BMI. As with weight, average
BMI was lower after dieting in both diet groups, but with no
difference detected at either 3–6 months across the 4 trials
reporting this (Table 10; Figure S2A in Supporting Information
S2), or in the one trial reporting this at 1–2 years (Table 11; Figure
S2B in Supporting Information S2).
Blood pressure. At 3–6 months, the average DBP compared
to baseline in each study was reduced in both the low CHO group
(range: 210 to 21 mmHg) and in those on balanced diets (range:
214 to 21 mmHg). At 1–2 years, the average drop within studies
compared to baseline ranged from 9 mmHg lower to no change in
DBP with low CHO and a reduction across studies with balanced
diets of 11 to 1 mmHg.
The meta-analyses of the mean difference in DBP change did
not demonstrate a difference between the low CHO and balanced
diets at 3–6 months (95%CI 21.53 to 1.36; 8 trials) (Table 10;
Figure S2C in Supporting Information S2) and at 1–2 years
(95%CI 21.68 to 1.62; 6 trials) (Table 11; Figure S2D in
Supporting Information S2). (In one of the trials [26], the mean
SBP value after three months in the low CHO group was reported
as 103.1613.7 mmHg (corresponding reported mean baseline
value of 138.6616.8 mmHg). We suspected this very low SBP
value to be a typographical error, but did not receive a response
after contacting the authors and therefore excluded this data from
the meta-analysis.)
At 3–6 months, the average SBP in each study compared to
baseline showed a drop in both the low CHO (range: 215 to 2
2 mmHg) and balanced diet groups (range: 216 to 21 mmHg) in
all trials. At 1–2 years, average SBP decreased with low CHO
(range: 210.6 to 20.9 mmHg) and either decreased or increased
with balanced diets (range: 210 to 8 mmHg). The increase was
observed in a small trial (n = 25) with 48% attrition when the trial
ended after one year [31].
The meta-analysis of the mean difference in SBP change
showed no difference after 3–6 months (21.26 mmHg, 95%CI 2
2.67 to 0.15; 7 trials) (Table 10; Figure S2E in Supporting
Information S2) and after 1–2 years (22.00 mmHg, 95%CI 2
5.00 to 1.00; 6 trials) (Table 11; Figure S2F in Supporting
Information S2).
Blood lipids. At 3–6 months, compared to baseline, average
LDL and total cholesterol were inconsistent across trials with low
CHO diets (range LDL: 20.62 to 0.3 mmol/L; total cholesterol:
20.71 to 0.1 mmol/L), while these values decreased with
balanced diets in each of the 12 trials that reported these values
(range LDL: 20.82 to 20.03 mmol/L; total cholesterol: 20.88 to
20.07 mmol/L). Average changes in HDL and TG from baseline
varied with low CHO (range HDL: 20.07 to 0.1 mmol/L; TG:2
0.64 to 0.01 mmol/L) and balanced diets (range HDL: 20.1 to
0.08 mmol/L; TG: 20.49 to 0.01 mmol/L). At 1–2 years,
average lipid marker changes from baseline were inconsistent in
both diet groups across trials, with variations in ranges of change
that were similar to those reported at 3–6 months.
The meta-analyses of the mean differences in blood lipids
between the low CHO and balanced diets were small in both
follow-up categories, with narrow confidence intervals suggesting
little or no difference in effect between the two diets (Tables 10 and
11; Figures S2G to S2N in Supporting Information S2).
Fasting blood glucose. From baseline to 3–6 months,
average FBG decreased with low CHO (range 20.47 to
20.06 mmol/L) and balanced diets (range 20.52 to 2
0.1 mmol/L), and at 1–2 years average changes were variable
with low CHO (range: 20.71 to 0.17 mmol/L) and balanced diets
(range: of 20.4 to 0.06 mmol/L). The meta-analysis showed no
difference between low CHO and balanced diets in FBG change
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at either 3–6 months (0.05 mmol/l, 95%CI 20.05 to 0.15; 10
trials; Figure S2O in Supporting Information S2) or 1–2 years
(0.0 mmol/L, 95%CI 20.16 to 0.16; 6 trials; Figure S2P in
Supporting Information S2).
Trials in participants with type 2 diabetes
Total weight loss. Average weight loss was evident at 3–6
months with low CHO (range: 2.79 to 5.5 kg) and isoenergetic
balanced diets (range: 3.08 to 5.4 kg), and similarly with both diets
at 1–2 years (range low CHO diets: 2 to 3.9 kg; range balanced
Table 10. Summary of findings for meta-analysis of low carbohydrate diets compared with balanced diets for overweight and
obese adults: 3–6 months follow-up.
Patient or population: overweight and obese adults without type 2 diabetes
Settings: primary care
Intervention: low carbohydrate diets (includes high fat and high protein variants)
Comparison: balanced diets
Follow-up: 3–6 months after starting diet
Outcomes Balanced diets Low carbohydrate diets
No. of participants
(studies)
Quality of the
evidence
(GRADE)
Illustrative range of change in average
values from pre-diet levels by study:
range across studiesa
The effect difference with low carbohydrate
diets in randomised comparison to balanced
diets (95%CI)
Weight loss Lower by 2.65 to 9.4 kg 0.74 kg more weight lost 1745 ›››ﬁ
(could be 1.49 lost to a gain of 0.01) (14 studies) moderate1,2
BMI Lower by 1.6 to 2.4 kg/m2 0.25 kg/m2 lower BMI 673 ›››ﬁ
(could be 0.64 lower to 0.13 higher) (4 studies) moderate3
Diastolic Lower by 1 to 14 mmHg 0.08 mmHg lower diastolic blood pressure 1362 ››ﬁﬁ
blood pressure (could be 1.53 lower to 1.36 higher) (8 studies) low4,5
Systolic Lower by 1 to 16 mmHg 1.26 mmHg lower systolic blood pressure 1057 ›››ﬁ
blood pressure (could be 2.67 lower to 0.15 mmHg higher) (7 studies) moderate6
LDL cholesterol From 0.03 lower to 0.82 mmol/L higher 0.09 mmol/L higher LDL cholesterol 1603 ›››ﬁ
(could be 0 to 0.18 mmol/L higher) (12 studies) moderate7
HDL cholesterol From 0.1 lower to 0.08 mmol/L higher 0.03 mmol/L higher HDL cholesterol 1603 ››ﬁﬁ
(could be 0.01 lower to 0.08 mmol/L higher) (12 studies) low8,9
Total cholesterol Lower by 0.07 to 0.88 mmol/L 0.08 mmol/L higher total cholesterol 1603 ›››ﬁ
(could be 0.02 lower to 0.17 mmol/L higher) (12 studies) moderate7
Triglycerides From 0.49 lower to 0.01 mmol/L higher 0.05 mmol/L lower triglycerides 1603 ››ﬁﬁ
(could be 0.14 lower to 0.04 mmol/L higher) (12 studies) low10,11
CI: Confidence interval ;
aNote this is the univariate average change observed between follow-up and baseline in the control group.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded by 1 for risk of bias: 8 of 14 studies did not report adequate sequence generation and 13 studies did not report adequate allocation concealment. 4
studies had high total attrition (.20%) and 2 other studies had differential attrition.
2Not downgraded for inconsistency: no qualitative heterogeneity; some quantitative heterogeneity, to be expected.
3Downgraded by 1 for risk of bias: 1 study did not report adequate sequence generation, none of the studies reported on allocation concealment and 1 study had high
total attrition (.20%).
4Downgraded by 1 for risk of bias: 5 of 8 studies did not report adequate sequence generation and 7 studies did not report adequate allocation concealment. 2 studies
had high total attrition (.20%).
5Downgraded by 1 for inconsistency: Mean differences were on opposite sides of the line of no difference (I2 51%).
6Downgraded by 1 for risk of bias: 5 of 8 studies did not report adequate sequence generation and 7 studies did not report adequate allocation concealment. 2 studies
had high total attrition (.20%).
7Downgraded by 1 for risk of bias: 5 of 12 studies did not report adequate sequence generation and 11 studies did not report adequate allocation concealment. 3
studies had high total attrition (.20%) and 2 other studies had differential attrition.
8Downgraded by 1 for risk of bias: 6 of 12 studies did not report adequate sequence generation and 11 studies did not report adequate allocation concealment. 3
studies had high total attrition (.20%) and 2 studies had differential attrition.
9Downgraded by 1 for inconsistency: Mean differences were on opposite sides of the line of no difference (I2 63%).
10Downgraded by 1 for risk of bias: 6 of 12 studies did not report adequate sequence generation and 11 studies did not report adequate allocation concealment. 3
studies had had total attrition (.20%) and 2 studies had differential attrition.
11Downgraded by 1 for inconsistency: Mean differences were on opposite sides of the line of no difference (I2 72%).
doi:10.1371/journal.pone.0100652.t010
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diets: 2.1 to 6 kg) in all trials. The meta-analysis of the mean
difference in weight loss between the low CHO and balanced diets
did not demonstrate a difference at 3–6 months (0.82 kg, 95%CI
21.25 to 2.90; 5 trials) (Table 12; Figure 5); and at 1–2 years
(0.91 kg, 95%CI 22.08 to 3.89; 4 trials) (Table 13; Figure 6).
A single trial found no difference in BMI change between the
low CHO (high fat variant) and balanced diets at 3–6 months
(Figures S3A and S3B in Supporting Information S3).
Markers of glycaemic control. At 3–6 months, compared
to baseline, changes in average HbA1c varied across studies with
low CHO diets (range: 20.54 to 0%), and decreased in each study
with balanced diets (range: 20.51 to 20.3%). At 1–2 years,
average HbA1c changes from baseline were inconsistent in both
diet groups across trials (range low CHO: 20.23 to 0.1%;
balanced: 20.28 to 0.4%).
The meta-analyses of the mean difference in HbA1c change did
not demonstrate a difference between the low CHO and balanced
diets at 3–6 months (0.19%, 95%CI 20.0 to 0.39; 5 trials)
(Table 12; Figure S3C in Supporting Information S3) and at 1–2
years (0.01%, 95%CI 20.28 to 0.30, 4 trials) (Table 13; Figure
S3D in Supporting Information S3).
Similarly, no mean difference in FBG change between low
CHO and balanced diets was detected by meta-analysis of 2
studies at 3–6 months (Figure S3E in Supporting Information S3).
One trial reported no difference in FBG change after 15 months
(Figure S3F in Supporting Information S3).
Blood pressure. Average changes in DBP from baseline
varied at 3–6 months with low CHO (range: 24 to 2.24 mmHg)
and balanced diets (range: 23 to 1.63 mmHg) and also at 1–2
years (range low CHO: 25 to 0.21 mmHg; balanced: 26 to
2.5 mmHg).
The meta-analyses of the mean difference in DBP change did
not demonstrate a difference between the low CHO and balanced
diets at 3–6 months (95%CI 21.77 to 3.30; 4 trials) (Table 12;
Figure S3G in Supporting Information S3) and at1–2 years
(95%CI 21.95 to 2.13, 4 trials) (Table 13; Figure S3H in
Supporting Information S3).
The average SBP in each study compared to baseline showed a
drop in both the low CHO (range: 29 to 21 mmHg) and
balanced diets (range: 28 to 20.06 mmHg) at 3–6 months, with
varied changes at 1–2 years (range low CHO: 29 to 2.2 mmHg;
balanced: 211 to 3.7 mmHg).
The meta-analysis of the mean difference in SBP change
showed no difference after 3–6 months (95%CI 23.14 to 4.36; 4
trials) (Table 12; Figure S3I in Supporting Information S3) and
after 1–2 years (95%CI 23.10 to 3.72; 4 trials) (Table 13; Figure
S3J in Supporting Information S3).
Blood lipids. At 3–6 months, blood lipids (LDL, HDL, total
cholesterol, TG) showed variable changes from baseline in both
low CHO and balanced diets. Overall, changes from baseline were
inconsistent between the diet groups and for both follow-up
categories. The changes on meta-analysis were small suggesting
little or no difference in effect between the two diets (Table 12 and
13; Figures S3K to S3R in Supporting Information S3).
Figure 3. Forest plot of low carbohydrate versus balanced diets in overweight and obese adults for weight loss (kg) at 3–6 months.
doi:10.1371/journal.pone.0100652.g003
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Discussion
This review, including 19 RCTs with 3209 participants showed
there is probably little or no difference in changes in weight and
cardiovascular and diabetes risk factors with low CHO weight loss
diets compared to isoenergetic balanced weight loss diets. This was
in both overweight and obese adults without diabetes and those
with diabetes, with follow-up for up to two years. When reported,
energy intake was similar in the diet groups being compared, but
participants did not adhere fully to the prescribed macronutrient
goals for both diets in most trials.
Overweight and obese adults without type 2 diabetes
Weight loss. Participants lost weight in both groups, with
similar before and after average loss after 3–6 months, and 1–2
years of follow-up. There was little or no difference in weight loss
and change in BMI between the low CHO and balanced weight
loss diets in the two follow-up periods. The similar reported mean
energy intakes in the low CHO and balanced diet groups and the
corresponding similar average weight loss in the diet groups
supports the fundamental physiologic principle of energy balance,
namely that a sustained energy deficit results in weight loss
regardless of macronutrient composition of the diet [43].
Norms for defining ‘‘stable weight’’ are gaining less than or
equal to 2 kg and losing less than 2 kg [44] indicating that both
low CHO and balanced weight loss diets (or energy-restricted
diets) result in meaningful weight loss. Clearly, the goal of any
healthy weight loss strategy should be to achieve weight loss and to
subsequently maintain this over the long-term. The 2013 AHA/
ACC/TOS Guideline for the Management of Overweight and
Obesity in Adults state that strategies for weight maintenance after
Table 11. Summary of findings for low carbohydrate diets compared with balanced diets for overweight and obese adults at 1–2
years follow-up.
Patient or population: overweight and obese adults without type 2 diabetes
Settings: primary care
Intervention: low carbohydrate diets (includes high fat and high protein variants)
Comparison: balanced diets
Follow-up: 1–2 years after starting diet
Outcomes Balanced diets Low carbohydrate diets
No. of participants
(studies)
Quality of the
evidence (GRADE)
Illustrative range of change in average
values from pre-diet levels by study:
range across studiesa
The effect difference with low carbohydrate
diets in randomised comparison to balanced
diets (95%CI)
Weight loss Lower by 3.5 to 10.9 kg 0.48 kilograms more weight lost 1025 ›››ﬁ
(could 1.44 lost to a gain of 0.49 kg) (7 studies) moderate1
BMI Lower by 1.5 kg/m2 0.40 kg/m2 lower BMI (high fat variant only) 200 ››ﬁﬁ
(at 1 year) (could be 0.94 lower to 0.14 higher) (1 study) low2,3
Diastolic Lower by 1 to 11 mmHg 0.03 mmHg lower diastolic blood pressure 914 ›››ﬁ
blood pressure (could be 1.68 lower to 1.62 mmHg higher) (6 studies) moderate4
Systolic From 10 lower to 8 mmHg higher 2 mmHg lower systolic blood pressure 914 ›››ﬁ
blood pressure (could be 5 lower to 1 mmHg higher) (6 studies) moderate4
LDL cholesterol From 0.79 lower to 0.06 mmol/L higher 0.07 mmol/L higher LDL cholesterol 915 ›››ﬁ
(could be 0.01 lower to 0.16 mmol/L higher) (6 studies) moderate4
HDL cholesterol From 0.03 lower to 0.15 mmol/L higher 0.04 mmol/L higher HDL cholesterol 986 ›››ﬁ
(could 0.01 to 0.08 mmol/L higher) (7 studies) moderate1
Total cholesterol From 0.76 lower 0.13 mmol/L higher 0.06 mmol/L higher total cholesterol 915 ›››ﬁ
(could be 0.03 lower to 0.16 mmol/L higher) (6 studies) moderate4
Triglycerides From 0.44 lower to 0.06 mmol/L higher 0.06 mmol/L lower triglycerides 915 ›››ﬁ
(could be 0.14 lower to 0.03 mmol/L higher) (6 studies) moderate4
CI: Confidence interval;
aNote this is the univariate average change observed between follow-up and baseline in the control group.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded by 1 for risk of bias: 5 of 7 studies did not report adequate sequence generation and only 1 reported adequate allocation concealment. 5 studies were
judged to have a high or unclear risk of attrition bias.
2Downgraded by 1 for risk of bias: the study did not report adequate allocation concealment and reasons for attrition differed between groups.
3Downgraded by 1 for imprecision: difference in mean BMI change ranges from a reduction of 20.94 to an increase of 0.14 kg/m2 (approximately equivalent to 2 to
4 kilograms).
4Downgraded by 1 for risk of bias: 4 of 6 studies did not report adequate sequence generation and 5 studies did not report adequate allocation concealment. 2 studies
had high total attrition (.20%), 1 of which also had differential attrition.
doi:10.1371/journal.pone.0100652.t011
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successful loss differ from the strategies for achieving weight loss
and make recommendations in this regard [44].
Impacts on markers of cardiovascular risk. Weight loss
improves markers of cardiovascular risk [45–47]. According to the
2013 AHA/ACC/TOS Guideline [44], based largely on system-
atic reviews, clinically meaningful changes in CVD risk indicators
are associated with a loss of at least 2.5 kg, or 2% of body weight,
achieved with lifestyle interventions over one to four years. This
document states that at a 5% weight loss, a weighted mean
reduction in DBP of about 2 mmHg and in SBP of about
3 mmHg is observed [44]. Correspondingly, the weight loss in
both diet groups in our review was accompanied by reductions in
average DBP and SBP in all trials. In line with the weight loss
findings, there is probably little or no difference in SBP changes
after 3–6 months and there may be little or no difference in DBP
changes between the low CHO and balanced diet groups. After 1–
2 years, there is probably little or no difference in changes in DBP
and SBP between the diet groups. These judgements are based on
both the meta-analyses and the quality of the evidence for these
outcomes per length of follow-up category.
When considering blood lipid changes, a weight loss of 5 kg to
8 kg is reported to result in LDL cholesterol reduction of
approximately 0.13 mmol/L and an increase in HDL cholesterol
of between 0.05 to 0.08 mmol/L [44]. In overweight and obese
adults with and without CVD risk who lose 3 kg on a lifestyle
intervention, a weighted reduction in serum TG of approximately
0.17 mmol/L is observed [44]. In the trials in our review, effects on
blood lipids and FBG with low CHO and balanced diets were
variable, with greater and lesser average changes in LDL, HDL and
TG than the observations described above. When comparing low
CHO and isoenergetic balanced diets, the pooled mean differences
across the trials and quality of evidence indicate that there is
probably little or no difference in changes in LDL, HDL and total
cholesterol and there may be little or no difference in TG change at
3–6 months. Similarly, after 1–2 years, there is probably little or no
difference in serum LDL and total cholesterol and TG between the
diet groups. Meta-analysis of HDL cholesterol difference was
0.04 mmol/L higher with low CHO diets compared to balanced
diets after 1–2 years, but the difference was not clinically
meaningful, and no difference was detected for LDL.
The primary reason for the moderate grade of evidence in most
outcomes at 3–6 months and 1–2 years is the risk of selection,
performance and attrition bias in most included trials. For serum
triglycerides, inconsistency (as discussed above) in effects resulted
in further downgrading to low quality indicative of less confidence
in the findings. Similarly, for DBP at 3–6 months, inconsistency in
the mean differences across the different trials resulted in further
downgrading to low quality evidence. This inconsistency could not
be explained by the different variants of the low CHO diet. Most
of the inconsistency can be ascribed to two trials [32,41] with
similar weights in the meta-analysis (19.5% and 15.5%, respec-
tively) that produced significant opposite mean differences for
DBP. Klemsdal and colleagues [32] found that the low CHO diet
reduced DBP more than the balanced diet (23.40 mmHg, 95%CI
26.02 to 20.78). They reported that this observation should be
interpreted with some caution, since blood pressure was a
secondary endpoint in the study and the effect on SBP did not
differ between the two groups. This effect was no longer significant
at one year. In contrast, Wycherley and colleagues [41] reported a
greater reduction in DBP with the balanced diet compared to the
low CHO diet (4.00 mmHg, 95%CI 0.58 to 7.42). Similarly, this
difference in effect was not found for SBP and disappeared at one
year. The heterogeneity may also be attributable to differences in
dietary adherence, as well as mean baseline DBP in one trial [27]
that could be judged as being imbalanced (85.8 and 80.7 mmHg
in low CHO and balanced diet groups, respectively). Although not
reported, it could be argued that differences in the sodium and
potassium content of the intervention diets may explain some of
the variable effects on DBP.
Overweight and obese adults with type 2 diabetes
mellitus
Weight loss. Both low CHO diets and balanced weight loss
diets showed similar weight loss on average after 3–6 months and
Figure 4. Forest plot of low carbohydrate versus balanced diets in overweight and obese adults for weight loss (kg) at 1–2 years.
doi:10.1371/journal.pone.0100652.g004
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after 1–2 years. Meta-analysis and quality of evidence indicate that
in overweight and obese adults with type 2 diabetes there may be
little or no difference in weight loss after 3–6 months and 1–2
years. The earlier discussion of the long-term effects of dieting on
weight loss is also applicable in this population.
Impacts on glycaemic control and cardiovascular
risk. Weight loss is associated with improvements in glycaemia
in overweight and obese adults with type 2 diabetes. According to
the 2013 AHA/ACC/TOS Guideline, 2% to 5% weight loss
achieved with one to four years of lifestyle intervention results in
modest reductions in FBG and lowering of HbA1c by 0.2% to
0.3% [44]. Along with weight loss in both diet groups in our
included trials, both low CHO and balanced diet groups showed
similar reductions in average HbA1c in most trials after 3–6
months. At 1–2 years average HbA1c change was more variable.
Comparing these changes by combining data across trials
indicated that there is probably little or no difference in changes
in HbA1c between the two diets at 3–6 months and 1–2 years. The
meta-analysis at 3–6 months of two small trials [25,40] showed
similar findings for FBG concentrations. Only one of these trials
went on to report FBG at 15 months and had the same finding
[25].
Effects on DBP with low CHO and balanced diets were variable
in most trials, showing both reductions and increases. Both the low
Table 12. Summary of findings for low carbohydrate diets compared with balanced diets for overweight and obese adults with
type 2 diabetes mellitus at 3–6 months follow-up.
Patient or population: overweight or obese adults with type 2 diabetes
Settings: primary care
Intervention: low carbohydrate diets (includes high fat and high protein variants)
Comparison: balanced diets
Follow-up: 3–6 months after starting diet
Outcomes Balanced diets Low carbohydrate diets
No. of participants
(studies)
Quality of the
evidence (GRADE)
Illustrative range of change in average
values from pre-diet levels by study:
range across studiesa
The effect difference with low carbohydrate
diets in randomised comparison to balanced
diets (95%CI)
Weight loss Lower by 3.08 to 5.4 kg 0.82 kg less weight lost 599 ››ﬁﬁ
(could be 1.25 lost to a gain of 2.9 kg) (5 studies) low1,2
HbA1c Lower by 0.3 to 0.51% 0.19% higher HbA1c 599 ›››ﬁ
(could be 0 to 0.39% higher) (5 studies) moderate3
Diastolic From 3 lower to 1.63 mmHg higher 0.77 mmHg higher diastolic blood pressure 545 ›››ﬁ
blood pressure (could be 1.77 lower to 3.3 mmHg higher) (4 studies) moderate4
Systolic Lower by 0.06 to 8 mmHg 0.61 mmHg higher systolic blood pressure 545 ››ﬁﬁ
blood pressure (could be 3.14 lower to 4.36 mmHg higher) (4 studies) low4,5
LDL cholesterol From 0.11 lower to 0.09 mmol/L higher 0.06 mmol/L higher LDL cholesterol 599 ›››ﬁ
(could be 0.11 lower to 0.23 mmHg higher) (5 studies) moderate3
HDL cholesterol From 0.01 lower to 0.03 mmol/L higher 0.01 lower HDL cholesterol 599 ›››ﬁ
(could be 0.05 lower to 0.04 mmol/L higher) (5 studies) moderate3
Total cholesterol Lower by 0.01 to 0.31 mmol/L 0.04 mmol/L higher total cholesterol 599 ›››ﬁ
(could be 0.21 lower to 0.3 mmol/L higher) (5 studies) moderate3
Triglycerides From 0 to 0.45 mmol/L lower 0.20 mmol/L lower triglycerides 252 ››ﬁﬁ
(could be 0.45 lower to 0.05 mmol/L higher) (4 studies) low6,7
CI: Confidence interval;
aNote this is the univariate average change observed between follow-up and baseline in the control group.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded by 1 for risk of bias: 1 of 5 studies did not report adequate sequence generation and 3 of 5 studies did not report adequate allocation concealment. 1
study had high total attrition (.20%) and 2 studies had differential attrition.
2Downgraded by 1 for imprecision: difference in mean weight loss ranges from a loss of 1.25 to a gain of 2.9 kilograms.
3Downgraded by 1 for risk of bias: 1 out of 5 studies did not report adequate sequence generation and 3 out of 5 studies did not report allocation concealment. 1 study
had high total attrition and 2 studies had differential attrition.
4Downgraded by 1 for risk of bias: 2 of 4 studies did not report adequate allocation concealment. 1 study had high total attrition (.20%) and 2 studies had differential
attrition.
5Downgraded by 1 for imprecision: difference in mean systolic blood pressure ranges from a reduction of 3.14 to an increase of 4.36 mmHg.
6Downgraded for risk of bias: 1 of 4 studies did not report adequate sequence generation and 2 studies did not report adequate allocation concealment. 2 studies had
differential attrition.
7Downgraded by 1 for imprecision: confidence interval range is 0.5 mmol/L.
doi:10.1371/journal.pone.0100652.t012
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CHO and balanced weight loss diets demonstrated reductions in
average SBP in all trials after 3–6 months, but effects were variable
with both diets after 1–2 years. Based on both the meta-analyses
and the quality of the evidence, there is probably little or no
difference in DBP change between the two diets and there may be
little or no difference in SBP change after 3–6 months. After 1–2
years, there is probably little or no difference in changes in both
DBP and SBP.
Effects on blood lipids with low CHO and balanced diets were
variable between included trials, as was seen in the non-diabetic
population. Considering the meta-analyses and the quality of the
evidence, there is probably little or no difference in changes in
LDL, HDL and total cholesterol after 3–6 months and 1–2 years
when comparing the two diets. There may be little or no difference
in changes in TG concentrations after 3–6 months and 1–2 years.
As in the non-diabetic overweight and obese population, the
presence of risk of selection, performance and attrition bias in most
included trials were the primary reasons for the moderate grade of
evidence in most outcomes in the diabetic population. For weight
loss at 3–6 months and 1–2 years follow-up, imprecision of the
effect estimates resulted in further downgrading to low quality
evidence. Similarly, the evidence for triglycerides for both follow-
up categories and for SBP at 3–6 months was downgraded due to
imprecision of the effect estimates. These imprecise estimates
possibly relate to the smaller samples in the diabetes population.
Adherence
Assessment of adherence to energy prescriptions across the 19
trials was problematic due to the different methods used to express
prescriptions and the lack of reported energy intake data in some
trials. The dietary intake methodology used also varied between
the included trials, with trials using food records/diaries, single or
multiple 24 hour recalls, food frequency questionnaires or
combinations of these methods.
From the calculated adherence scores it was clear that strict
adherence to prescribed macronutrient goals failed with both diets
in most trials and generally declined with longer follow-up. This
diminished adherence after the first few months has been well
documented in weight loss trials [48–51] and is more likely in
weight loss diets involving extreme dietary changes such as drastic
restrictions of entire food groups. This is supported by the fact that
trials of low CHO diets have reported a very low incidence of
urinary ketosis after six months [49–51], which suggests that most
overweight participants in weight loss trials struggle to sustain a
low intake of CHO. It could thus be argued that overweight
participants following reduced energy weight loss diets in trials
tend to revert to their usual macronutrient intakes over time, but
may nonetheless, be able to lose weight if they are able to maintain
the energy deficit. The novelty factor attached to a particular diet,
media attention, and the opinion of the researchers involved could
possibly affect the adherence of participants to any type of diet. It
is clear from this and other research [52] that one of the pertinent
issues in the treatment of overweight and obesity relates to the
improvement of behavioural adherence to reduced dietary energy
intake. It should be noted that the adherence score is based on
calculations using mean reported intakes of macronutrients (% of
total energy) and thus does not consider the variation around the
mean.
Overall completeness and applicability of evidence
The findings of our review need to be interpreted in light of the
presence of risk of bias or lack of power or both in many of the
included trials, the possibility that adherence to dietary macronu-
trient goals were not optimal and that there was inter-trial
variation in quantity (and type) of fat consumed. The interpreta-
tion of many weight loss trials is limited by a lack of blinded
ascertainment of the outcome, small samples, large loss to follow-
up, potentially limited generalisability and a lack of data on
adherence to assigned diets [53]. These limitations all apply to the
Figure 5. Forest plot of low carbohydrate versus balanced diets in overweight and obese adults with type 2 diabetes for weight
loss (kg) at 3–6 months.
doi:10.1371/journal.pone.0100652.g005
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evidence assessed in our systematic review. Strengths of our review
include the clear definitions used in relation to the energy content
and macronutrient composition of treatment and control diets, as
well as the restriction of included studies to those testing diets only
thereby reducing the risk of confounding by co-interventions. By
considering only isoenergetic comparisons we also avoided the
problem of the effect of energy imbalance between the comparison
groups being confounded with any potential effect of macronu-
trient manipulation on the outcomes being investigated. Further-
more, we only included studies with follow-up of 12 weeks or more
to allow for sufficient time to detect weight and CVD risk factor
changes and assessed outcomes at defined lengths of follow-up.
These methods differentiate our systematic review from previous
reviews on this topic.
Our results show that the weight loss in overweight and obese
subjects with or without diabetes on isoenergetic low CHO or
balanced weight loss diets was similar at 3–6 months and at 1–2
years. Thus, the weight loss is the result of a reduction in total
dietary energy intake rather than manipulation of macronutrient
contribution. It follows that when considering dietary strategies for
weight loss, less emphasis should be placed on an ‘ideal’
macronutrient composition and more emphasis on reduction in
total energy intake, as well as improvement of behavioural
adherence to reduced energy intake. This will go a long way to
ensure that weight loss is achieved and maintained to gain health
Table 13. Summary of findings for low carbohydrate diets compared with balanced diets for overweight and obese adults with
type 2 diabetes mellitus at 1–2 years follow-up.
Patient or population: overweight or obese adults with type 2 diabetes
Settings: primary care
Intervention: low carbohydrate diets (high fat and high protein variants combined)
Comparison: balanced diets
Follow-up: 1–2 years after starting diet
Outcomes Balanced diets Low carbohydrate diets
No. of participants
(studies)
Quality of the
evidence (GRADE)
Illustrative range of change in average
values from pre-diet levels by study:
range across studiesa
The effect difference with low carbohydrate
diets in randomised comparison to balanced
diets (95%CI)
Weight loss Lower by 2.1 to 6 kg 0.91 kg less weight lost 492 ››ﬁﬁ
(could be 2.08 lost to a gain of 3.89) (4 studies) low1,2
HbA1c From 0.28% lower to 0.4% higher 0.01% higher HbA1c 492 ›››ﬁ
(could be 0.28 lower to 0.3 higher) (4 studies) moderate3
Diastolic From 6 lower to 2.5 mmHg higher 0.09 mmHg higher diastolic blood pressure 492 ›››ﬁ
blood pressure (could be 1.95 lower to 2.13 higher) (4 studies) moderate1
Systolic From 11 lower to 3.7 mmHg higher 0.31 mmHg higher systolic blood pressure 492 ›››ﬁ
blood pressure (could be 3.1 lower to 3.72 higher) (4 studies) moderate1
LDL cholesterol From 0.3 lower to 0.04 mmol/L higher 0.10 mmol/L higher LDL cholesterol 492 ›››ﬁ
(could be 0.06 lower to 0.27 higher) (4 studies) moderate3
HDL cholesterol Higher by 0.02 to 0.19 mmol/L No difference in HDL cholesterol 492 ›››ﬁ
(could be 0.09 lower to 0.08 higher) (4 studies) moderate3
Total cholesterol From 0.3 lower to 0.35 mmol/L higher 0.10 mmol/L higher total cholesterol 492 ›››ﬁ
(could be 0.12 lower to 0.31 mmol/L higher) (4 studies) moderate3
Triglycerides Lower by 0.1 to 0.3 mmol/L 0.08 mmol/L lower triglycerides 198 ››ﬁﬁ
(could be 0.49 lower to 0.26 higher) (3 studies) low4,5
CI: Confidence interval;
aNote this is the univariate average change observed between follow-up and baseline in the control group.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded by 1 for risk of bias: 2 of 4 studies did not report adequate allocation concealment. 1 study had high total attrition (.20%) and 2 studies had differential
attrition.
2Downgraded by 1 for imprecision: The 95% confidence interval includes both a loss of 2.08 kg and a gain of 3.89 kg.
3Downgraded by 1 for risk of bias: 2 of 4 studies did not report adequate allocation concealment, 2 studies had high total attrition (.20%), 2 studies had differential
attrition.
4Downgraded by 1 for risk of bias: 1 of 3 studies did not report adequate allocation concealment. 2 studies had high total attrition (.20%), 2 studies had differential
attrition.
5Downgraded by 1 for imprecision: confidence interval range is about 0.7 mmol/L.
doi:10.1371/journal.pone.0100652.t013
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benefits. Guidance on macronutrient composition to meet
nutritional requirements and prevent disease [12–15] remains
integral to healthy sustainable weight management.
The small size and short duration of weight loss trials often
account for their lack of definitive evidence of the effectiveness of
dietary interventions on CVD risk. By contrast sound observa-
tional data, population-level interventions and ‘‘natural experi-
ments’’ in whole populations have demonstrated a reduction in
population risk with adoption of recommended, balanced dietary
strategies to lower cardiovascular risk. For example, over the past
three decades, levels of population cardiovascular risk factors have
declined in Finland, with the greatest change being dietary
behaviour (reduction in total and saturated fat and increased
vegetables and fruit intake). These declines explain most of the
observed decline in CHD mortality in the Finnish middle-aged
population over this period [54]. Mortality due to coronary heart
disease was reduced in Poland over a ten year period by partly
replacing dietary saturated fats with polyunsaturated fats while
maintaining a low intake of trans fatty acids [55]. A large
prospective cohort study in 30 to 49 year old Swedish women
(n = 43396; average follow-up 15.7 years) reported significantly
increased incidence of cardiovascular disease overall (n = 1270)
with a one tenth decrease in carbohydrate intake or increase in
protein intake, or a two unit increase in the low carbohydrate-high
protein score [9].
Our systematic review did not address macronutrient quality of
the diets, specifically the quality of CHO and fat, which along with
total macronutrient quantities and proportions, explains the effects
of diet on cardiovascular risk [56]. The replacement nutrient is
central to these effects. When foods high in CHO are avoided and
replaced with high protein foods, reliance on animal protein
sources becomes necessary since most foods with significant
amounts of plant protein are also high in CHO (e.g. legumes). This
reliance on animal protein will result in a greater intake of both
total and especially saturated fat leading to higher serum HDL and
LDL cholesterol over time. Substitution of saturated fat with
polyunsaturated fats reduces coronary heart disease risk [57,58],
while substitution with high glycaemic index CHO increases risk
[59]. LDL-cholesterol is a causal risk factor for heart disease and
reducing LDL cholesterol has been shown to be effective in
reducing risk of heart disease irrespective of the presence of prior
heart disease, age, sex, hypertension and diabetes [60–62].
Mendelian randomisation studies have demonstrated a 54%
reduction in coronary heart disease risk per 1 mmol/l lower
serum LDL cholesterol over a lifetime [62]. Treatment of elevated
cholesterol levels reduces coronary heart disease risk, with clinical
trials demonstrating a 24% reduction in risk per 1 mmol/l
reduction in LDL over 5 years [60]. Furthermore, the role of ultra-
processed products in the etiology and treatment of obesity and
NCD is a pertinent consideration in this area [63,64]. The
inconsistent changes in blood lipids and markers of diabetes risk
with both diets in the trials may be attributable to differences in
the quality of macronutrients in the intervention diets, for
example, different intakes of saturated fat and/or types of
carbohydrates (low or high glycaemic), an issue which was beyond
the scope of our review. These inconsistences may also be
attributable to participants not fully adhering to the prescribed
total macronutrient goals for each of the diets, as evident from the
adherence data.
Any dietary guidelines for health should be sustainable in the
long-term, specifically in terms of ease of adherence, availability
and affordability of foods, as well as social and cultural
acceptability. Bearing this in mind, the dietary approach for
weight management should be one that is nutritionally sound, not
harmful and feasible to maintain over time. Such diets can be
tailored to the needs of individuals on the basis of each individual’s
complete health and risk profile, for example existing lipid
abnormalities and comorbidities, as well as food preferences,
socioeconomic circumstances and personal and cultural prefer-
ences, thereby improving the chances of longer term success.
Suitably qualified healthcare professionals should guide the
tailoring of dietary advice for individuals. Monitoring and
follow-up by a healthcare professional during a dietary weight
loss intervention is known to positively affect outcomes [16]. The
demonstrated value of combining dietary and other positive
lifestyle interventions such as increased physical activity for weight
loss and reduction of cardiovascular risk, is also important to keep
in mind [65,66].
Figure 6. Forest plot of low carbohydrate versus balanced diets in overweight and obese adults with type 2 diabetes for weight
loss (kg) at 1–2 years.
doi:10.1371/journal.pone.0100652.g006
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Potential biases in the review process
Three prominent electronic databases were searched and two
authors carried out the various steps in the review (screening and
selecting, extracting, risk of bias assessment, analysing, collation
and interpretation). Although we planned not to include non-
English randomised controlled trials, we did not come across any
potentially eligible studies that we needed to exclude based on
language.
Conclusions
Trials show weight loss in the short-term irrespective of whether
the diet is low CHO or balanced in terms of its macronutrient
composition. There is probably little or no difference in weight loss
and changes in cardiovascular risk factors up to two years of
follow-up when overweight and obese adults, with or without type
2 diabetes, are randomised to low CHO diets and isoenergetic
balanced weight loss diets.
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